IMMY is a United States based manufacturer of in vitro diagnostics with a product line consisting of diagnostic tests for fungal diseases. 

One of the more recent products developed by IMMY is a Cryptococcal Antigen Lateral Flow Assay (CrAg LFA), which is the first-and-only test of its kind, and has received praise from organizations like the World Health Organization and the Centers for Disease Control. 

IMMY takes pride in producing reliable, accurate diagnostics, but above all the company wants to play a role in raising the standard of healthcare for patients all over the world.

Link to IMMY